[The basic treatment of rheumatoid arthritis. Current trends].
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002216:Captopril / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D010396:Penicillamine / Q000627:therapeutic use; D011746:Pyrithioxin / Q000627:therapeutic use; D012164:Retinal Diseases / Q000139:chemically induced; D013946:Thymopoietins / Q000627:therapeutic use; D008625:Tiopronin / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D013946:Thymopoietins; D007978:Levamisole; D006886:Hydroxychloroquine; D006046:Gold; D002216:Captopril; D011746:Pyrithioxin; D008625:Tiopronin; D010396:Penicillamine
Le traitement de fond de la polyarthrite rhumatoïde. Tendances actuelles.